144 ·Filed Jun 15, 2026

STE

STERIS plc
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001921094-26-000650
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale tied to equity compensation vesting. Monitor for any larger-than-normal insider selling patterns in the coming weeks, but standalone this filing has no material market impact. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
STE ▲ +2.88% at T+60d
NEUTRAL call ✓ call won +2.88% · α vs SPY +1.88% · entry $206.51 → $212.45
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-3.44%
call -3.44% · α -2.19%
$199.40
settled 4mo ago
T+5d
-1.60%
call -1.60% · α +0.63%
$203.21
settled 3mo ago
T+20d
+1.07%
call +1.07% · α +0.88%
$208.73
settled 3mo ago
T+60d
+2.88%
call +2.88% · α +1.88%
$212.45
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Form 144 filed indicating John Adam Zangerle, an officer of STERIS plc, intends to sell 1,419 ordinary shares valued at approximately $297K. The shares were acquired via restricted stock lapses on June 1 and June 2, 2026, from equity compensation. The sale is small relative to the company's $20.3B market cap and is likely a routine transaction for tax withholding or personal liquidity, not a signal of deteriorating fundamentals.

Key Facts

  • Officer John Adam Zangerle filed Form 144 to sell 1,419 ordinary shares of STERIS plc
  • Estimated market value of the proposed sale: $296,968
  • Shares were acquired through restricted stock lapses on June 1, 2026 (820 shares) and June 2, 2026 (599 shares), both from equity compensation
  • Sale is a small fraction of STERIS's $20.3B market cap and does not appear to be a significant insider liquidation

Financial Impact

$297K sale by an officer, representing a negligible 0.0015% of STERIS's $20.3B market cap

dilution

Risk Factors

  • Proposed sale is only an intent — it may not be executed
  • Additional insider selling could emerge if management is de-risking ahead of earnings or M&A

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
67% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001921094-26-000650
Document: 0001921094-26-000650-index.html0001921094-26-000650
Document: 0001921094-26-000650.txt0001921094-26-000650
10 reports for STE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for STE — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
Press Release
NEUTRAL ★ 2/10
$230.34 $236.44▲ +2.65%▼ −0.73%$207.99 (−9.70%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$206.51 $208.73▲ +1.07%▲ +0.88%$207.99 (+0.72%)
Jun 11, 2026
16w ago
DEFA14A
NEUTRAL ★ 2/10
$207.56 $216.00▲ +4.07%▲ +2.29%$207.99 (+0.21%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$212.88 $215.39▲ +1.18%▼ −0.27%$207.99 (−2.30%)
Jun 5, 2026
16w ago
144
NEUTRAL ★ 2/10
$210.03 $213.28▲ +1.55%▼ −0.08%$207.99 (−0.97%)
Jun 4, 2026
17w ago
144
NEUTRAL ★ 2/10
$212.35 $213.28▲ +0.44%▼ −1.42%$207.99 (−2.05%)
May 11, 2026
20w ago
8-K
BEARISH ★ 7/10
$210.23 $208.10▲ +1.01%▼ −0.71%$207.99 (+1.07%)
May 11, 2026
20w ago
Press Release
MIXED ★ 6/10
$210.23 $208.10▼ −1.01%▲ +0.71%$207.99 (−1.07%)
May 7, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$207.24 $212.35▲ +2.47%▲ +2.44%$207.99 (+0.36%)
Apr 21, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$222.61 $214.42▼ −3.68%▼ −6.84%$207.99 (−6.57%)
Showing 10 of 10

US Market Status

Market Open — Closes in 2h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access